Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00709592 · OUTCOME

Relapse

Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT · Source last updated 2018-11-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percent patients relapsing
Interval / dispersion
Not reported
Time frame
2 year relapse rate (%)

What was measured

Patients with different disease relapses was determined according to current clinical standards based on the disease. For example, AML or MDS relapse is determined by a bone marrow biopsy. Multiple myeloma relapse requires a number of labs and/or biopsy to diagnose such as SPEP, UPEP, immunofixation, serum and urine light chains. In lymphoma disease is followed using CT and/or PET scans.

Groups in this outcome

A:Thymoglobulin: 1.7 mg/kg/Day

1.7 mg/kg/d thymoglobulin IV d-9 to -7

B:Thymoglobulin: 2.5 mg/kg/Day

2.5 mg/kg/d thymoglobulin IV d-9 to d-7

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
A:Thymoglobulin: 1.7 mg/kg/Day19
B:Thymoglobulin: 2.5 mg/kg/Day22

Reported measurements

Source class 1
Values in Percent patients relapsing · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
A:Thymoglobulin: 1.7 mg/kg/Day28Not reportedNot reportedNot reportedNot reported
B:Thymoglobulin: 2.5 mg/kg/Day50Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        28
      2. group Id
        OG001
        value
        50
denoms
  1. counts
    1. group Id
      OG000
      value
      19
    2. group Id
      OG001
      value
      22
    units
    Participants
description
Patients with different disease relapses was determined according to current clinical standards based on the disease. For example, AML or MDS relapse is determined by a bone marrow biopsy. Multiple myeloma relapse requires a number of labs and/or biopsy to diagnose such as SPEP, UPEP, immunofixation, serum and urine light chains. In lymphoma disease is followed using CT and/or PET scans.
groups
  1. description
    1.7 mg/kg/d thymoglobulin IV d-9 to -7
    id
    OG000
    title
    A:Thymoglobulin: 1.7 mg/kg/Day
  2. description
    2.5 mg/kg/d thymoglobulin IV d-9 to d-7
    id
    OG001
    title
    B:Thymoglobulin: 2.5 mg/kg/Day
param Type
NUMBER
reporting Status
POSTED
time Frame
2 year relapse rate (%)
title
Relapse
type
SECONDARY
unit Of Measure
Percent patients relapsing

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice